跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PALFORZIA 20 MG POLVO ORAL EN CAPSULAS PARA ABRIR - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PALFORZIA 20 MG POLVO ORAL EN CAPSULAS PARA ABRIR
Approved
STANDARD
PALFORZIA 20 MG POLVO ORAL EN CAPSULAS PARA ABRIR
Stallergenes
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 29, 2022
Approval ID
044e1cb27f7fab1d
Company
Stallergenes
Type
Standard
Approval Details
Approval Id
044e1cb27f7fab1d
Drug Cima Aemps Name
PALFORZIA 20 MG POLVO ORAL EN CAPSULAS PARA ABRIR
Register Number
1201495006
Holder Company Name
Stallergenes
Marketing Company Name
Stallergenes
Holder Company Detail Path
/organization/stallergenes
Marketing Company Detail Path
/organization/stallergenes
Authorization Date
2022-07-29
Dosage Form
POLVO ORAL EN ENVASE UNIDOSIS
Dose
20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Stallergenes
Company Detail Path
/organization/stallergenes
Company Information
Pharmaceutical Company Name
STALLERGENES
Country Name
France
City Name
antony,ile de france,country_fr
Address
6 RUE ALEXIS DE TOCQUEVILLE
Active Ingredients
CACAHUETE POLVO DESENGRASADO, SEMILLAS
40 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 29, 2022
Approval ID
044e1cb27f7fab1d
Type
Standard
Back to CIMA-AEMPS Approvals
